Trials / Completed
CompletedNCT06849778
An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis
A Phase 1, Open-label, Pharmacokinetic Study of TS-172 in Patients on Hemodialysis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
A phase 1, open-label, pharmacokinetic study of TS-172 in patients on hemodialysis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-172 | oral administration of TS-172 20 mg |
Timeline
- Start date
- 2025-03-22
- Primary completion
- 2025-04-24
- Completion
- 2025-04-24
- First posted
- 2025-02-27
- Last updated
- 2025-05-15
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06849778. Inclusion in this directory is not an endorsement.